Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (757)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (757)
Apply filters
Showing 731 to 740 of 757
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Upadacitinib for treating moderately to severely active ulcerative colitis
TA856
4 January 2023
4 January 2023
Upadacitinib for treating severe rheumatoid arthritis
TA665
9 December 2020
9 December 2020
Ustekinumab for moderately to severely active Crohn's disease after previous treatment
TA456
12 July 2017
12 July 2017
Ustekinumab for the treatment of adults with moderate to severe psoriasis
TA180
23 September 2009
3 March 2017
Ustekinumab for treating active psoriatic arthritis
TA340
4 June 2015
3 March 2017
Ustekinumab for treating moderately to severely active ulcerative colitis
TA633
17 June 2020
17 June 2020
Vandetanib for treating medullary thyroid cancer
TA550
12 December 2018
12 December 2018
Varenicline for smoking cessation
TA123
25 July 2007
25 July 2007
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
TA352
26 August 2015
26 August 2015
Previous page
1
…
72
73
Current page
74
75
76
Page
74
of
76
Next page
Results per page
10
25
50
All
Back to top